IntroductionLymphatic endothelium plays essential roles in regulating fluid and chemokine-dependent antigen-presenting cell (APC) movement from peripheral sites to draining lymph nodes (LNs). 1 The chemokine family 2 is functionally subdivided into inflammatory and constitutive subsets. 3 Inflammatory chemokines are involved in recruiting leukocytes to sites of infection or damage, whereas constitutive chemokines are involved in more precise, tissuespecific, trafficking, including movement into secondary lymphoid organs as part of the adaptive immune response. Initiation of adaptive immune responses requires selective migration of APCs expressing the constitutive chemokine receptor, CCR7, to LNs. 4 To facilitate this, lymphatic endothelium selectively expresses, and presents, the CCR7 ligands CCL19 and CCL21. However, in the context of inflamed peripheral tissues, in which inflammatory chemokines will be abundant, it is unclear how selective presentation of constitutive chemokines by lymphatic endothelium is achieved.In addition to the family of signaling chemokine receptors, we and others have been studying a subfamily of atypical chemokine receptors characterized by an apparent inability to signal after ligand binding. 5,6 Further studies have shown some of these receptors to be active as chemokine-scavenging receptors, implicating them in negative regulation of chemokine-driven processes. [7][8][9] We are particularly interested in the D6 chemokine-scavenging receptor. 10 This molecule scavenges by binding inflammatory CC-chemokines with high affinity, internalizing them, and targeting them for intracellular degradation. D6 does not bind, or alter cellular responses to, constitutive CC-chemokines, such as CCL19 or CCL21, or chemokines belonging to any other subfamily and is therefore specific for inflammatory CC-chemokines. 5,[10][11][12] In D6-deficient mice, exaggerated inflammatory responses have been observed, in all tissues in which D6 is normally expressed, 5,[13][14][15][16][17][18] indicating its importance for resolution of in vivo inflammatory responses. However, the major site of D6 expression in vivo is on lymphatic endothelial cells (LECs), 19 and it is difficult to argue for a major role for these cells in inflammatory chemokine scavenging. 20 In addition, D6 is expressed on some leukocyte subtypes, 17,21 including macrophages 19 but predominantly on B cells and dendritic cells (DCs), which are not cells that are typically attracted to, and able to scavenge chemokines at, the epicenter of inflammatory responses. Thus, the cellular basis for in vivo D6 function is currently unclear. In particular, the roles for D6 on LECs have remained elusive.Here we have focused specifically on roles for D6 on lymphatic endothelium and its importance for fluid and cellular trafficking from peripheral tissues to LNs. We report that D6 plays an essential function in regulating lymph flow and cellular efflux from inflamed peripheral sites to draining LNs. D6 achieves this role by preventing The online version of t...